Washington University geneticist Dr. Jimmy Lin’s Rare Genomics Institute and Scientist of San Diego have announced the winners of about $500,000 in...

The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...

By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly 15...

This article discusses how the pharmaceutical industry can leverage its competencies in outsourcing to accelerate time to market, improve quality...

It’s not hard to find articles, blog posts, or market reports these days that state contract research organizations, and outsourcing in general, is...

Last month we ran a series of blog posts about next generation sequencing. Among the topics discussed were the limitations of next generation...

We’ve covered many different aspects of pharmaceutical innovation, ranging from organizational structure, patents, and incubators, but are there...

Although pharmaceutical companies and contract research organizations operate in the same preclinical drug discovery space, working for the two...

Here at Scientist, for the past few weeks we’ve been running a series of blog posts about stem cells discussing why iPS make an attractive research...

In our previous post on stem cells, we discussed how human-derived induced pluripotent stem cells (iPS) are being used to model “disease in a...